Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1

NCT02687230 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Pancreatic Carcinoma
Tumors That Express CA19-9

Interventions

DRUG: MVT-2163
DRUG: MVT-5873

Sponsor

BioNTech Research & Development, Inc.

Collaborators

[object Object]